Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).
Saved in:
| Title: | Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study). |
|---|---|
| Authors: | Alexopoulos A; 'HYGEIA' Hospital, Athens, Greece; a.alexo@yahoo.gr., Karanikiotis C; 'EUROMEDICA' General Clinic, Thessaloniki, Greece., Ardavanis A; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece., Boukovinas I; 'BIOKLINIKI' Hospital, Thessaloniki, Greece., Makrantonakis P; INTERBALKAN Medical Center, Thessaloniki, Greece., Papadimitriou C; 'IASO' General Hospital, Athens, Greece., Athanasiadis A; 'Koutlimbaneio and Triantafylleio' General Hospital, Larissa, Greece., Boutis A; 'THEAGENEIO' Anticancer Hospital, Thessaloniki, Greece., Giassas S; 'REA' Hospital, Athens, Greece., Kakolyris S; University General Hospital of Alexandroupolis, Alexandroupolis, Greece., Koumakis G; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece., Papazisis K; 'EUROMEDICA' General Clinic, Thessaloniki, Greece., Psyrri A; 'ATTIKO' University General Hospital, Athens, Greece., Ziras N; 'Metaxa' Anticancer Hospital of Piraeus, Piraeus, Greece., Baka S; INTERBALKAN Medical Center, Thessaloniki, Greece., Kentepozidis N; 251 Airforce General Hospital, Athens, Greece., Michalaki V; 'ARETAIEIO' Hospital, Athens, Greece. |
| Source: | Anticancer research [Anticancer Res] 2022 Feb; Vol. 42 (2), pp. 1031-1041. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35093904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alexopoulos+A%22">Alexopoulos A</searchLink>; 'HYGEIA' Hospital, Athens, Greece; a.alexo@yahoo.gr.<br /><searchLink fieldCode="AU" term="%22Karanikiotis+C%22">Karanikiotis C</searchLink>; 'EUROMEDICA' General Clinic, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Ardavanis+A%22">Ardavanis A</searchLink>; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Boukovinas+I%22">Boukovinas I</searchLink>; 'BIOKLINIKI' Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Makrantonakis+P%22">Makrantonakis P</searchLink>; INTERBALKAN Medical Center, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Papadimitriou+C%22">Papadimitriou C</searchLink>; 'IASO' General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Athanasiadis+A%22">Athanasiadis A</searchLink>; 'Koutlimbaneio and Triantafylleio' General Hospital, Larissa, Greece.<br /><searchLink fieldCode="AU" term="%22Boutis+A%22">Boutis A</searchLink>; 'THEAGENEIO' Anticancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Giassas+S%22">Giassas S</searchLink>; 'REA' Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Kakolyris+S%22">Kakolyris S</searchLink>; University General Hospital of Alexandroupolis, Alexandroupolis, Greece.<br /><searchLink fieldCode="AU" term="%22Koumakis+G%22">Koumakis G</searchLink>; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Papazisis+K%22">Papazisis K</searchLink>; 'EUROMEDICA' General Clinic, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Psyrri+A%22">Psyrri A</searchLink>; 'ATTIKO' University General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Ziras+N%22">Ziras N</searchLink>; 'Metaxa' Anticancer Hospital of Piraeus, Piraeus, Greece.<br /><searchLink fieldCode="AU" term="%22Baka+S%22">Baka S</searchLink>; INTERBALKAN Medical Center, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Kentepozidis+N%22">Kentepozidis N</searchLink>; 251 Airforce General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Michalaki+V%22">Michalaki V</searchLink>; 'ARETAIEIO' Hospital, Athens, Greece. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228102988%22">Anticancer research</searchLink> [Anticancer Res] 2022 Feb; Vol. 42 (2), pp. 1031-1041. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>8102988 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-7530 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202507005%22">02507005 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35093904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21873/anticanres.15564 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1031 Titles: – TitleFull: Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alexopoulos A – PersonEntity: Name: NameFull: Karanikiotis C – PersonEntity: Name: NameFull: Ardavanis A – PersonEntity: Name: NameFull: Boukovinas I – PersonEntity: Name: NameFull: Makrantonakis P – PersonEntity: Name: NameFull: Papadimitriou C – PersonEntity: Name: NameFull: Athanasiadis A – PersonEntity: Name: NameFull: Boutis A – PersonEntity: Name: NameFull: Giassas S – PersonEntity: Name: NameFull: Kakolyris S – PersonEntity: Name: NameFull: Koumakis G – PersonEntity: Name: NameFull: Papazisis K – PersonEntity: Name: NameFull: Psyrri A – PersonEntity: Name: NameFull: Ziras N – PersonEntity: Name: NameFull: Baka S – PersonEntity: Name: NameFull: Kentepozidis N – PersonEntity: Name: NameFull: Michalaki V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2022 Feb Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1791-7530 Numbering: – Type: volume Value: 42 – Type: issue Value: 2 Titles: – TitleFull: Anticancer research Type: main |
| ResultId | 1 |
